CAR-Modified T-Cell Therapy As Potential Fresh Treatment For Non-Hodgkin Lymphomas Results of a fresh explore entitled “ Phase II trial of chimeric antigen receptor modified T cells directed against CD19 in relapsed/refractory diffuse large B cell, follicular, and mantle cell lymphomas” were recently introduced during […]